Organon's Q1 2025 earnings report showed significant declines across key financial metrics, leading to a drastic 30% drop in ...

BofA analyst Jason Gerberry lowered the firm’s price target on Organon (OGN) to $10 from $11 and keeps an Underperform rating ...